Evidence map›Paper›PMID 42258720›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Chemical neighborhood exploration for substrate discovery in biocatalysis.

Yaroslav V Solovev, Nikita N Kostin, Yuri A Prokopenko, Patrick Masson, Ivan V Smirnov, Hongkai Zhang, Wei Zheng, Igor A Yaroshevich, Alexey V Stepanov, Petr A Popov and 1 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yaroslav V Solovev *Department of Peptide and Protein Technologies, M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia.
Nikita N Kostin *Department of Peptide and Protein Technologies, M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia.ORCID 0000-0001-9447-9961
Yuri A ProkopenkoDepartment of Peptide and Protein Technologies, M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia.ORCID 0000-0002-2603-5506
Patrick MassonInstitute of Fundamental Medicine and Biology, Kazan Federal University, Kazan 420008, Russia.ORCID 0000-0002-7837-3662
Ivan V SmirnovDepartment of Peptide and Protein Technologies, M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia.ORCID 0000-0002-0384-6568
Hongkai ZhangThe National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, School of Statistics and Data Science, Academy for Advanced Interdisciplinary Studies, Key Laboratory of Pure Mathematics and Combinatorics and Key Laboratory for Medical Data Analysis and Statistical Research, Nankai University, Tianjin 300071, People's Republic of China.
Wei ZhengThe National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, School of Statistics and Data Science, Academy for Advanced Interdisciplinary Studies, Key Laboratory of Pure Mathematics and Combinatorics and Key Laboratory for Medical Data Analysis and Statistical Research, Nankai University, Tianjin 300071, People's Republic of China.
Igor A YaroshevichDepartment of Biophysics, Faculty of Biology, Lomonosov Moscow State University, Moscow 119991, Russia.
Alexey V StepanovDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037.ORCID 0000-0003-1616-4408
Petr A PopovSchool of Science, Constructor University Bremen, Bremen 28759, Germany.
Alexander G GabibovDepartment of Peptide and Protein Technologies, M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia.ORCID 0000-0001-8665-3288

Funding

MOST | National Natural Science Foundation of China (NSFC) 12426303MOST | National Natural Science Foundation of China (NSFC) 82261138553MOST | National Natural Science Foundation of China (NSFC) 82373898
6 · The paper itself

Abstract

Predicting the substrate reactivity strength for a given biocatalyst remains a central challenge in computational biocatalysis. Here, we present Subdate, a modular workflow that combines descriptor-guided organization of substrate analogs with ab initio metadynamics simulations to prioritize reactive candidates. The workflow integrates i) substrate library construction, ii) conformer generation and descriptors set definition, iii) library clustering, iv) representative-substrate selection, and v) reaction-barrier quantitative prediction. Applied to selected biocatalysts (human butyrylcholinesterase and the catalytic antibody A17) sharing an SN2 reaction mechanism, Subdate quantitatively identifies reactivity trends that match experimental kinetic measurements. The developed workflow provides a mechanism-aware strategy for reactive substrate prioritization for efficient sampling through the chemical library in biocatalysis.

Indexed as

BiocatalysisButyrylcholinesteraseHumansKineticsMolecular Dynamics SimulationSubstrate SpecificityButyrylcholinesteraseBader theorybiocatalysischemical spaceorganophosphorusQM/MM metadynamics

Identifiers

PMID42258720
PMCPMC13273237

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.